{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:49:04Z","timestamp":1787932144249,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972780"],"award-info":[{"award-number":["81972780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010051"],"award-info":[{"award-number":["2020A1515010051"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.gendis.2025.101859","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:02:42Z","timestamp":1758610962000},"page":"101859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Fang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7887-9586","authenticated-orcid":false,"given":"Keping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gendis.2025.101859_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gendis.2025.101859_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2017.04.024","article-title":"Cancer incidence and mortality in China, 2013","volume":"401","author":"Chen","year":"2017","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.gendis.2025.101859_bib3","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"issue":"7123","key":"10.1016\/j.gendis.2025.101859_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"issue":"7123","key":"10.1016\/j.gendis.2025.101859_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O'Brien","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2025.101859_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.physiol.010908.163253","article-title":"The role of CLCA proteins in inflammatory airway disease","volume":"71","author":"Patel","year":"2009","journal-title":"Annu Rev Physiol"},{"issue":"8\u20139","key":"10.1016\/j.gendis.2025.101859_bib7","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/jcb.29550","article-title":"A prognostic eight-gene expression signature for patients with breast cancer receiving adjuvant chemotherapy","volume":"121","author":"Cui","year":"2020","journal-title":"J Cell Biochem"},{"issue":"6","key":"10.1016\/j.gendis.2025.101859_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/10445490152122442","article-title":"Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer","volume":"20","author":"Bustin","year":"2001","journal-title":"DNA Cell Biol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101859_bib9","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.18632\/aging.101571","article-title":"CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K\/AKT signaling","volume":"10","author":"Liu","year":"2018","journal-title":"Aging"},{"issue":"26","key":"10.1016\/j.gendis.2025.101859_bib10","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.gendis.2025.101859_bib11","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2217\/fon-2017-0696","article-title":"Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer","volume":"14","author":"Sarshekeh","year":"2018","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101859_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001499","article-title":"RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study","volume":"8","author":"Cohen","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.gendis.2025.101859_bib13","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101859_bib14","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/mt.2013.160","article-title":"Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality","volume":"21","author":"Radvanyi","year":"2013","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.gendis.2025.101859_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/life12020184","article-title":"Identification, culture and targeting of cancer stem cells","volume":"12","author":"Herreros-Pomares","year":"2022","journal-title":"Life"},{"issue":"5","key":"10.1016\/j.gendis.2025.101859_bib16","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.18632\/oncotarget.3205","article-title":"Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with granzyme B+ CD8+ T-cell infiltration","volume":"6","author":"Zumwalt","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.gendis.2025.101859_bib17","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/gutjnl-2016-313498","article-title":"Gut microbiota modulate T cell trafficking into human colorectal cancer","volume":"67","author":"Cremonesi","year":"2018","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.gendis.2025.101859_bib18","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210108","article-title":"Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10","volume":"218","author":"Mowat","year":"2021","journal-title":"J Exp Med"},{"issue":"626","key":"10.1016\/j.gendis.2025.101859_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf0992","article-title":"TRIB3 reduces CD8+ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer","volume":"14","author":"Shang","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101859_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2118210","article-title":"CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy","volume":"11","author":"Li","year":"2022","journal-title":"Oncoimmunology"},{"issue":"54","key":"10.1016\/j.gendis.2025.101859_bib21","doi-asserted-by":"crossref","first-page":"93001","DOI":"10.18632\/oncotarget.21724","article-title":"CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K\/AKT pathway","volume":"8","author":"Hou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2025.101859_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1649344","article-title":"Expression of the CLCA4 gene in esophageal carcinoma and its impact on the biologic function of esophageal carcinoma cells","volume":"2021","author":"Song","year":"2021","journal-title":"J Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101859_bib23","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200963","article-title":"CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer","volume":"40","author":"Han","year":"2020","journal-title":"Biosci Rep"},{"issue":"6","key":"10.1016\/j.gendis.2025.101859_bib24","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1053\/j.gastro.2020.12.080","article-title":"Clinical implications of colorectal cancer stem cells in the age of single-cell omics and targeted therapies","volume":"160","author":"Frank","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gendis.2025.101859_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.02.019","article-title":"Cancer cells stemness: a doorstep to targeted therapy","volume":"1866","author":"Prasad","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101859_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101859_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/cancers3010319","article-title":"The role of colorectal cancer stem cells in metastatic disease and therapeutic response","volume":"3","author":"Anderson","year":"2011","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.gendis.2025.101859_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.gendis.2025.101859_bib29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/0008-5472.CAN-08-3078","article-title":"Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem\/progenitor cells","volume":"69","author":"Luo","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101859_bib30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/1871520611313040006","article-title":"FAK and Nanog cross talk with p53 in cancer stem cells","volume":"13","author":"Golubovskaya","year":"2013","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"11","key":"10.1016\/j.gendis.2025.101859_bib31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5483\/BMBRep.2018.51.11.180","article-title":"STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells","volume":"51","author":"Jang","year":"2018","journal-title":"BMB Rep"},{"issue":"4","key":"10.1016\/j.gendis.2025.101859_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284871","article-title":"FAK downregulation suppresses stem-like properties and migration of human colorectal cancer cells","volume":"18","author":"Xu","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2025.101859_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","article-title":"Focal adhesion kinase: from biological functions to therapeutic strategies","volume":"12","author":"Tan","year":"2023","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101859_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111968","article-title":"CD44+CD24\u2013\/low sphere-forming cells of EBV-associated gastric carcinomas show immunosuppressive effects and induce Tregs partially through production of PGE2","volume":"390","author":"Hui","year":"2020","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1016\/j.gendis.2025.101859_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ncb3090","article-title":"Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"14","key":"10.1016\/j.gendis.2025.101859_bib36","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1158\/0008-5472.CAN-18-2659","article-title":"microRNA-92 expression in CD133+ melanoma stem cells regulates immunosuppression in the tumor microenvironment via integrin-dependent activation of TGF\u03b2","volume":"79","author":"Shidal","year":"2019","journal-title":"Cancer Res"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225003484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225003484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:32:20Z","timestamp":1774053140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225003484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2352304225003484"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101859","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101859"}}